Naprosyn vs. Relafen: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Naprosyn and Relafen. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 103,062 people who take Naprosyn and Relafen, and is updated regularly.
What is Naprosyn?
Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 16,738 Naprosyn users. Check the latest studies of Naprosyn.
What is Relafen?
Relafen has active ingredients of nabumetone. It is often used in arthritis. eHealthMe is studying from 6,243 Relafen users. Check the latest studies of Relafen.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
103,062 people who take Naprosyn and Relafen are studied.
Drugs being compared in this study:
- Relafen (nabumetone)
- Naprosyn (naproxen)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Naprosyn:
- not at all: 5.98 %
- somewhat: 28.85 %
- moderate: 38.57 %
- high: 20.73 %
- very high: 5.88 %
Relafen:
- not at all: 5.38 %
- somewhat: 32.58 %
- moderate: 33.99 %
- high: 22.1 %
- very high: 5.95 %
Want to compare Naprosyn with Relafen?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
- Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH, "Nabumetone use and risk of acute pancreatitis in a case-control study", Pancreatology, 2016 Jun .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Relafen:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on naproxen and nabumetone (the active ingredients of Naprosyn and Relafen, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ranitidine cause Pathological Fracture? - 6 seconds ago
- Could Coumadin cause Albumin Globulin Ratio Decreased? - 8 seconds ago
- Could Azithromycin cause Respiratory Syncytial Virus Infection? - 12 seconds ago
- Could Farxiga cause Gastritis? - 16 seconds ago
- Could Emtricitabine cause Ultrasound Antenatal Screen Abnormal? - 20 seconds ago
- Could Azithromycin cause Psychological Trauma? - 20 seconds ago
- Urinary Tract Disorder and Erythema Multiforme - 24 seconds ago
- Drug interactions of Doxycycline and Adenosine - 25 seconds ago
- Could Omeprazole cause Herpes Simplex? - 31 seconds ago
- Could Ketoconazole cause Squamous Cell Carcinoma Of Skin? - 39 seconds ago